DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Xu W, Lu C, Zhang F, Shao J, Yao S, Zheng S.
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
FEBS J 2017;
284 (01) 114-133
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.